Age-related skin changes, including thinning of the dermis and loss of subcutaneous fat, make older adults more susceptible to bruising
Experience the benefits of FDA-approved GLP-1 treatments with expert medical guidance
Gorrell MD, Wickson J, McCaughan GW
GLP-1 Agonists Market Size, Share & Trends Analysis Report By Product (Branded GLP-1 Agonists, Dual / Triple, Biosimilars & Generic GLP-1 Agonists Agonists), By Indication (Type 2 Diabetes Mellitus, Obesity / Overweight Management, Cardiovascular & Metabolic Related Indications, Other Emerging Indications (e.g., NASH, Alzheimers-related)), By Route of Administration, By Distribution Channel, By Region and By Segments Forecasts, 2025-2034 GLP-1 Agonists Market Size is valued at USD 43.1 Bn in 2024 and is predicted to reach USD 260.1 Bn by the year 2034 at an 19.9% CAGR during the forecast period for 2025-2034
doi: 10.1007/s11356-023-28745-w
An average of 7.9 3.8 kg of weight was lost as a result of liraglutide medication, which also markedly improved general health and sexual performance
